We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Synchrony Financial's (SYF) Q3 Earnings?
Read MoreHide Full Article
Synchrony Financial (SYF - Free Report) will release third-quarter 2020 results on Oct 20, before the market opens.
The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is pegged at 78 cents per share, suggesting a 36.1% drop from the year-ago reported figure, mainly due to COVID-19-led muted revenues.
In the last reported quarter, the company reported earnings per share of 6 cents per share, beating the Zacks Consensus Estimate by 50%. However, the bottom line plunged 95.9% year over year, thanks to depressed revenues.
Key Catalysts for Q3 Earnings
The company’s revenues might have been affected by the coronavirus situation in the quarter under review. It is likely to have witnessed lower interest and fees on loans from its Retail Card, Payment Solutions and CareCredit segments. The Zacks Consensus Estimate for the top line is pegged at $3.4 billion, indicating a 21% downfall from the year-earlier reported number. The consensus mark for net interest income stands at $3.5 billion, hinting at a 20.8% fall from the prior-year reported number.
Synchrony Financial is also expected to have endured elevated expenses due to operational losses and certain expenditures related to its response to COVID-19.
In the to-be-reported quarter, weak purchase volume is likely to have persisted due to lower travel, entertainment, events, etc.
The Zacks Consensus Estimate for efficiency ratio is 33.7%, implying a rise from the year-ago reported figure of 30.8%.
Nonetheless, he company is expected to have consistently gained from digital sales volume.
In Retail Card, the company is likely to have witnessed a hike in digital sales and mobile channel.
What the Quantitative Model Predicts
Our proven model predicts an earnings beat for Synchrony Financial this reporting cycle. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise, which you can see below. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: Synchrony Financial has an Earnings ESP of +8.71%. This is because the Most Accurate Estimate is pegged at 84 cents, higher than the Zacks Consensus Estimate of 78 cents per share. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Synchrony Financial Price, Consensus and EPS Surprise
Zacks Rank: Synchrony Financial currently carries a Zacks Rank #3 (Hold), which increases the predictive power of ESP.
Other Stocks to Consider
Some other stocks worth considering from the finance sector with a perfect mix of elements to also surpass estimates in the upcoming quarterly releases are as follows:
Equitable Holdings, Inc. (EQH - Free Report) is set to report third-quarter earnings on Nov 4. The stock currently has a Zacks Rank #2 and an Earnings ESP of +4.74%.
Capital One Financial Corporation (COF - Free Report) has an Earnings ESP of +10.74% and is presently Zacks #3 Ranked. The company is scheduled to release third-quarter earnings on Oct 22.
Moodys Corporation (MCO - Free Report) is slated to announce third-quarter earnings on Oct 29. The stock has an Earnings ESP of +5.22% and is a #2 Ranked player, presently.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration. Download Marijuana Moneymakers FREE >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
What's in Store for Synchrony Financial's (SYF) Q3 Earnings?
Synchrony Financial (SYF - Free Report) will release third-quarter 2020 results on Oct 20, before the market opens.
The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is pegged at 78 cents per share, suggesting a 36.1% drop from the year-ago reported figure, mainly due to COVID-19-led muted revenues.
In the last reported quarter, the company reported earnings per share of 6 cents per share, beating the Zacks Consensus Estimate by 50%. However, the bottom line plunged 95.9% year over year, thanks to depressed revenues.
Key Catalysts for Q3 Earnings
The company’s revenues might have been affected by the coronavirus situation in the quarter under review. It is likely to have witnessed lower interest and fees on loans from its Retail Card, Payment Solutions and CareCredit segments. The Zacks Consensus Estimate for the top line is pegged at $3.4 billion, indicating a 21% downfall from the year-earlier reported number. The consensus mark for net interest income stands at $3.5 billion, hinting at a 20.8% fall from the prior-year reported number.
Synchrony Financial is also expected to have endured elevated expenses due to operational losses and certain expenditures related to its response to COVID-19.
In the to-be-reported quarter, weak purchase volume is likely to have persisted due to lower travel, entertainment, events, etc.
The Zacks Consensus Estimate for efficiency ratio is 33.7%, implying a rise from the year-ago reported figure of 30.8%.
Nonetheless, he company is expected to have consistently gained from digital sales volume.
In Retail Card, the company is likely to have witnessed a hike in digital sales and mobile channel.
What the Quantitative Model Predicts
Our proven model predicts an earnings beat for Synchrony Financial this reporting cycle. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise, which you can see below. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: Synchrony Financial has an Earnings ESP of +8.71%. This is because the Most Accurate Estimate is pegged at 84 cents, higher than the Zacks Consensus Estimate of 78 cents per share. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Synchrony Financial Price, Consensus and EPS Surprise
Synchrony Financial price-consensus-eps-surprise-chart | Synchrony Financial Quote
Zacks Rank: Synchrony Financial currently carries a Zacks Rank #3 (Hold), which increases the predictive power of ESP.
Other Stocks to Consider
Some other stocks worth considering from the finance sector with a perfect mix of elements to also surpass estimates in the upcoming quarterly releases are as follows:
Equitable Holdings, Inc. (EQH - Free Report) is set to report third-quarter earnings on Nov 4. The stock currently has a Zacks Rank #2 and an Earnings ESP of +4.74%.
Capital One Financial Corporation (COF - Free Report) has an Earnings ESP of +10.74% and is presently Zacks #3 Ranked. The company is scheduled to release third-quarter earnings on Oct 22.
Moodys Corporation (MCO - Free Report) is slated to announce third-quarter earnings on Oct 29. The stock has an Earnings ESP of +5.22% and is a #2 Ranked player, presently.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>